| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.5 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |